The French company agreed to buy the U.S. supplier of software to the life-sciences industry, as it seeks to bolster its artificial-intelligence offering.
The French company agreed to buy the U.S. supplier of software to the life-sciences industry, as it seeks to bolster its artificial-intelligence offering.